Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Oncology Institute, Inc.

Get SEC filing alerts via email and in your feed for Oncology Institute, Inc.

TOI TOIIW DFPH

Oncology Institute, Inc.

About Oncology Institute, Inc.

The Oncology Institute, Inc. specializes in outpatient oncology care, offering fee-for-service and value-based contracts across multiple states. It operates clinics providing medical oncology, radiation therapy, pharmacy services, and clinical trials, primarily serving adult and senior populations. The company emphasizes evidence-based, cost-efficient care aligned with clinical guidelines, partnering with payors to manage oncology populations and improve outcomes while reducing costs.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Oncology Institute, Inc.

1
1
Oncology Institute, Inc. The Oncology Institute Reports 41.2% Revenue Growth to $147.4 Million in Q1 2026

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
Oncology Institute, Inc. The Oncology Institute Reports $502.7 Million Revenue with 27.8% Growth for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Oncology Institute, Inc. The Oncology Institute Reports 36.7% Revenue Growth but Incurred $16.5 Million Net Loss in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Oncology Institute, Inc. The Oncology Institute Reports $119.8 Million Revenue for Q2 2025, Despite Net Loss

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Oncology Institute, Inc. The Oncology Institute Reports $104.4 Million Revenue in Q1 2025, Despite Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Oncology Institute, Inc. The Oncology Institute Reports 21.3% Revenue Growth to $393.4 Million for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Oncology Institute, Inc. The Oncology Institute Reports 21.8% Revenue Growth, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments